Patent · US Active

Fused ring inhibitors of hepatitis C

US9150554B2 · kind B2 · utility

1Cited by

9References

13Claims

0Family size

Assignee

Presidio Pharmaceuticals, Inc. · US

Inventors

Leping Li · San Francisco, US
Min Zhong · Palo Alto, US

Key dates

Filing date	Mar 25, 2010
Grant date	Oct 6, 2015
Priority date	—
Expiry date	Mar 25, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compounds of Formula I, pharmaceutical compositions comprising the same, and combination therapies comprising the same for treatment of hepatitis C.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.